Hybrid (Indica-leaning)

Tahoe OG | Cannabis Strain Review & Effects

SFV OG x Unknown OG

Tahoe OG is a hybrid-leaning indica strain (SFV OG x Unknown OG) with THC levels of 20-25%. It features a Myrcene-dominant terpene profile and is known for relaxed and sleepy. Best used during the night.

THC

20-25%

CBD

0-1%

Best Time

Night

Primary Effects

RelaxedSleepyEuphoricHappyHungry

Flavor Notes

Earthy, Lemon, Pine, Woody

Aroma

Earthy aroma with pine and lemon notes

Research Sources

29 peer-reviewed studies

Verified Via

PubMed / DOI

Evidence

Research-Backed

Updated

December 2025

Every claim cites peer-reviewed research
How We Research

What is Tahoe OG?

Tahoe OG is a hybrid-leaning indica strain (SFV OG x Unknown OG) with THC levels of 20-25%. It features a Myrcene-dominant terpene profile and is known for relaxed and sleepy. Best used during the night.

About Tahoe OG Strain

Tahoe OG is a indica-dominant hybrid cannabis strain created by crossing SFV OG x Unknown OG, bred by GajnGreen Gardens. With THC levels ranging from 20% to 25%, Tahoe OG is considered a high-potency strain that delivers powerful effects.

Users of Tahoe OG commonly report feeling relaxed, sleepy, euphoric, happy. The effects often start with a wave of mental relaxation that gradually spreads throughout the body. As the high deepens, physical tension melts away, making it ideal for unwinding after a long day. Ideal for nighttime use, its sedating qualities can help prepare the body and mind for restful sleep.

Medical cannabis patients frequently turn to Tahoe OG for relief from insomnia, chronic pain, stress, muscle spasms. Myrcene, the dominant terpene, is associated with sedative and muscle-relaxant properties that may enhance the strain's therapeutic potential.

Due to its high potency, Tahoe OG is best suited for experienced cannabis consumers. New users should approach with caution, starting with a very small dose and waiting to assess effects before consuming more. Common side effects may include dry mouth, dry eyes, couch lock. Staying well-hydrated and having snacks on hand can help minimize discomfort.

The aroma of Tahoe OG is characterized by earthy, pine, lemon notes that create a distinctive sensory profile. On the palate, expect earthy, lemon, pine flavors that develop throughout each session. The myrcene-dominant terpene profile is largely responsible for these aromatic and flavor characteristics, contributing to the entourage effect that shapes the overall experience.

Related Reading

Commonly Used For

Patients often seek Tahoe OG for relief from the following conditions:

Note: These are commonly reported uses based on patient experiences. Individual results may vary. Always consult with a healthcare provider to determine if medical cannabis is appropriate for your specific condition.

Potential Side Effects

Be aware of these commonly reported side effects when using Tahoe OG:

Dry MouthDry EyesCouch Lock

How to minimize side effects

  • Start with a low dose, especially if new to cannabis
  • Stay hydrated before, during, and after use
  • Use in a comfortable, familiar environment
  • Avoid mixing with alcohol or other substances

Terpene Profile

Myrcenedominant
Earthy, musky, clove-like~0.8%

Primary research: Sedation & Relaxation

Limoneneprimary
Citrus, lemon, orange~0.4%

Primary research: THC Anxiety Reduction

Spicy, peppery, woody, clove-like~0.2%

Primary research: Anti-inflammatory

Concentration Levels

Dominant (>1.0%)
Primary (0.5-1.0%)
Secondary (0.1-0.5%)
Trace (<0.1%)

Cannabinoid Profile

THCPsychoactive

20-25%

Pain Relief

0-1%

Seizure Reduction

Therapeutic Profile Matches

Based on Tahoe OG's terpene and cannabinoid profile, it may be well-suited for these therapeutic applications:

migraines

70%
Good Match
  • High myrcene content supports migraines & headaches
  • thc dominant ratio matches profile
  • Best used night, aligning with condition needs

nausea

67%
Good Match
  • High limonene content supports nausea & appetite loss
  • thc dominant ratio matches profile
  • High beta-caryophyllene content supports nausea & appetite loss

ptsd

67%
Good Match
  • High myrcene content supports ptsd & trauma
  • High beta-caryophyllene content supports ptsd & trauma
  • thc dominant ratio matches profile

muscle spasms

65%
Good Match
  • High myrcene content supports muscle spasms & spasticity
  • High beta-caryophyllene content supports muscle spasms & spasticity
  • Best used night, aligning with condition needs

anxiety

57%
Moderate Match
  • High limonene content supports anxiety
  • High beta-caryophyllene content supports anxiety
  • Best used night, aligning with condition needs

Match scores are theoretical

These scores are based on terpene/cannabinoid research and do not guarantee specific effects. Individual responses vary significantly. Always consult a healthcare provider.

  1. 1

    Surendran S, et al. Myrcene-What Are the Potential Health Benefits of This Flavouring and Aroma Agent? Frontiers in Nutrition. 2021

    Comprehensive review: β-myrcene may potentiate the anti-nociceptive properties of cannabinoids.

  2. 2

    Johnson MB, et al. The Effects of β-myrcene on Simulated Driving and Divided Attention: A Double-Blind, Placebo-Controlled, Crossover Pilot Study Cannabis. 2023

    Found myrcene alone did not significantly impair simulated driving performance.

  3. 3

    do Vale TG, et al. Central effects of citral, myrcene and limonene, constituents of essential oil chemotypes from Lippia alba (Mill.) n.e. Brown Phytomedicine. 2002

    Demonstrated dose-dependent sedative and motor-relaxant effects of myrcene in mice.

  4. 4

    Lorenzetti BB, et al. Myrcene mimics the peripheral analgesic activity of lemongrass tea Journal of Ethnopharmacology. 1991

    Found peripheral analgesic activity in animal models.

  5. 5

    Liktor-Busa E, et al. Analgesic Potential of Terpenes Derived from Cannabis sativa Pharmacological Reviews. 2021

    Comprehensive review of cannabis terpene analgesic effects including myrcene.

  6. 6

    Tagen M, et al. Vaporized D-limonene selectively mitigates the acute anxiogenic effects of Δ9-tetrahydrocannabinol Drug and Alcohol Dependence. 2024

    Johns Hopkins study showing limonene specifically reduces THC-induced anxiety in humans.

  7. 7

    Vieira AJ, et al. Limonene: Aroma of innovation in health and disease Chemico-Biological Interactions. 2018

    Comprehensive review of limonene's anxiolytic and antidepressant effects.

  8. 8

    Kiecolt-Glaser JK, et al. Olfactory influences on mood and autonomic, endocrine, and immune function Psychoneuroendocrinology. 2008

    Lemon scent exposure improved mood and reduced norepinephrine.

  9. 9

    Sun J. D-Limonene: safety and clinical applications Alternative Medicine Review. 2007

    D-limonene showed gastroprotective effects and clinical safety.

  10. 10

    Gertsch J, et al. β-Caryophyllene is a dietary cannabinoid Proceedings of the National Academy of Sciences. 2008

    Landmark paper: BCP directly activates CB2 receptors.

  11. 11

    Klauke AL, et al. The cannabinoid CB2 receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain European Journal of Pain. 2014

    Showed dual mechanism for neuropathic pain relief.

  12. 12

    Bahi A, et al. β-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice Physiology & Behavior. 2014

    BCP reduced anxiety via CB2 receptor activation.

  13. 13

    Horvath B, et al. β-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner Free Radical Biology and Medicine. 2012

    BCP reduced inflammation markers and oxidative stress.

  14. 14

    Tambe Y, et al. Gastric cytoprotection of the non-steroidal anti-inflammatory sesquiterpene, beta-caryophyllene Planta Medica. 1996

    BCP protected gastric mucosa in ulcer models.

  15. 15

    Gaoni Y, Mechoulam R. Isolation, structure, and partial synthesis of an active constituent of hashish Journal of the American Chemical Society. 1964. doi:10.1021/ja01062a046

    Landmark paper first identifying and synthesizing THC.

  16. 16

    Whiting PF, et al. Cannabinoids for medical use: A systematic review and meta-analysis JAMA. 2015

    Comprehensive review finding moderate evidence for chronic pain.

  17. 17

    Aviram J, Samuelly-Leichtag G. Efficacy of Cannabis-Based Medicines for Pain Management: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Pain Physician. 2017

    Systematic review of clinical trials for neuropathic pain.

  18. 18

    Lutge EE, et al. The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS Cochrane Database of Systematic Reviews. 2013

    Systematic review of cannabis for HIV/AIDS symptoms including appetite.

  19. 19

    Smith LA, et al. Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy Cochrane Database of Systematic Reviews. 2015

    High-quality evidence for CINV efficacy.

  20. 20

    Kesner AJ, Lovinger DM. Cannabinoids, Endocannabinoids and Sleep Frontiers in Molecular Neuroscience. 2020

    Review of THC effects on sleep architecture.

  21. 21

    Novotna A, et al. A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols (Sativex), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis European Journal of Neurology. 2011

    Phase III trial showing efficacy for MS spasticity.

  22. 22

    Silvestro S, et al. Molecular Targets of Cannabidiol in Experimental Models of Neurological Disease Molecules. 2020

    Comprehensive review of CBD's therapeutic applications and molecular targets.

  23. 23

    Thiele EA, et al. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial Lancet. 2018

    Phase III trial leading to FDA approval of Epidiolex.

  24. 24

    Devinsky O, et al. Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial Lancet Neurology. 2016

    Open-label trial showing 36.5% reduction in seizures.

  25. 25

    Shannon S, et al. Cannabidiol in anxiety and sleep: A large case series Permanente Journal. 2019

    79.2% of patients reported reduced anxiety within first month.

  26. 26

    Bergamaschi MM, et al. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients Neuropsychopharmacology. 2011

    CBD reduced anxiety in simulated public speaking test.

  27. 27

    Burstein S. Cannabidiol (CBD) and its analogs: a review of their effects on inflammation Bioorganic & Medicinal Chemistry. 2015

    Review of CBD's anti-inflammatory mechanisms.

  28. 28

    Shannon S, et al. Cannabidiol in Anxiety and Sleep: A Large Case Series Permanente Journal. 2019

    66.7% of patients reported improved sleep in this anxiety and sleep study.

  29. 29

    Urits I, et al. Use of cannabidiol (CBD) for the treatment of chronic pain Best Practice & Research Clinical Anaesthesiology. 2020

    Comprehensive review of CBD for chronic pain management.

Research Verification

All citations link directly to PubMed or the original source. You can verify any claim by clicking the reference link. Learn more about how we research.

Frequently Asked Questions

What are the effects of Tahoe OG?

Tahoe OG is known for producing relaxed, sleepy, euphoric, happy effects. As a hybrid indica, it's typically best suited for night use.

What conditions might Tahoe OG help with?

Tahoe OG is commonly used by patients seeking relief from insomnia, chronic pain, stress, muscle spasms. Always consult with a healthcare provider before using cannabis for medical purposes.

How strong is Tahoe OG?

Tahoe OG is considered a high-potency strain with THC levels typically ranging from 20-25%. New users should approach with caution and start with a low dose.

What does Tahoe OG taste and smell like?

Tahoe OG features earthy, lemon, pine flavors with a earthy, pine, lemon aroma. Its unique terpene combination creates a memorable sensory experience.

What are the side effects of Tahoe OG?

Common side effects include dry mouth, dry eyes, couch lock. Staying hydrated and starting with a low dose can help minimize these effects.

Quick Facts

Type
Hybrid (Indica-leaning)
Genetics
SFV OG x Unknown OG
Breeder
GajnGreen Gardens
Best Time of Use
Night
Availability
moderate
Grow Difficulty
moderate
Experience Level
Experienced Users

Want to try Tahoe OG? Get your medical marijuana card today.

Get Your Card

Similar Strains

If you like Tahoe OG, try these

OG KushSFV OGFire OG

Related by Genetics

Educational Information

This content is for educational purposes only and is not medical advice. Consult a healthcare provider before using cannabis products.

Strain Variability

Profiles vary between batches, growers, and growing conditions. Always check lab test results for the specific product you're purchasing.

Beyond Indica/Sativa

Effects are better predicted by cannabinoid and terpene profiles than strain classification. Focus on the chemistry, not the label.

Understanding Therapeutic Profiles

Learn how terpenes and cannabinoids work together to create each strain's unique effects and therapeutic potential through the entourage effect.

Learn About Therapeutic Profiles